vimarsana.com

Page 10 - கோட்டை எஸ்கார்ட்ஸ் இதயம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

107-year-old Delhi man gets Covid vaccine shot

107-year-old Delhi man gets Covid vaccine shot ​ By IANS | Published on ​ Mon, Mar 15 2021 21:12 IST | ​ 7 Views 107-year-old man becomes oldest person in India to receive Covid vaccine.. Image Source: IANS News New Delhi, March 15 : A 107-year-old man became the oldest person to receive the Covid-19 vaccine after receiving his first shot on Monday. The man, Kewal Krishan, was inoculated in a private hospital under the supervision of his cardiologist Dr Ashok Seth, Chairman, Fortis Escorts Heart Institute, Delhi. The man lives in South Delhi and had undergone a major heart surgery two years ago. As per the hospital, he is the oldest patient in the world to have undergone stenting to the artery of the left side of the brain.

Delhi man, aged 107, gets COVID vaccine shot

PM Modi s mother receives first jab of COVID Vaccine A 107-year-old man became the oldest person to receive the Covid-19 vaccine after receiving his first shot on Monday. The man, Kewal Krishan, was inoculated in a private hospital under the supervision of his cardiologist Dr Ashok Seth, Chairman, Fortis Escorts Heart Institute, Delhi. The man lives in South Delhi and had undergone major heart surgery two years ago. As per the hospital, he is the oldest patient in the world to have undergone stenting to the artery of the left side of the brain. The surgery was done to prevent Krishan from a major brain stroke, Dr Seth said.

107-year-old man gets COVID-19 jab

Meril Life Sciences launches indigenously researched and developed thin-strut bioresorbable scaffold, MeRes100

Meril Life Sciences launches indigenously researched and developed thin-strut bioresorbable scaffold, MeRes100 - BRS, in India Kolkata, Mar 10 (UNI) Meril Life Sciences today announced the launch of its indigenously researched and developed bioresorbable scaffold (BRS) MeRes100 in India. Bioresorbable scaffolds are non-metallic, non-permanent mesh tubes, similar to stents, that dissolve over time after ensuring the previously blocked artery is opened via a routine angioplasty procedure. This novel therapy option, which can meaningfully treat an identified subset of the patient population, will be launched in a phased, sequential manner to ensure adherence to best clinical practices and continued development of clinical research and long-term evidence.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.